Oligonucleotide-based Strategies to Inhibit Human Hepatitis C Virus

Oligonucleotides

Volumn 13, Issue 6, 2003, Pages 539-548

  Martinand Mari, Camille ^a   Lebleu, Bernard ^a   Robbins, Ian ^a  

^a UNIVERSITÉ DE MONTPELLIER   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ANTISENSE OLIGONUCLEOTIDE; ANTIVIRUS AGENT; GENOMIC RNA; OLIGONUCLEOTIDE; RIBONUCLEASE H; RIBOZYME; SMALL INTERFERING RNA; VIRUS PROTEIN;

CELL FREE SYSTEM; GENE EXPRESSION REGULATION; GENETIC TRANSFECTION; GENOTYPE; HEPATITIS C; HEPATITIS C VIRUS; HEPATOMA CELL; INTERNAL RIBOSOME ENTRY SITE; NONHUMAN; PRIORITY JOURNAL; PROTEIN ASSEMBLY; PROTEIN STRUCTURE; REVIEW; STEREOCHEMISTRY; TRANSLATION INITIATION; VIRUS INHIBITION;

ANTIVIRAL AGENTS; BASE SEQUENCE; HEPACIVIRUS; MOLECULAR SEQUENCE DATA; OLIGONUCLEOTIDES, ANTISENSE; RNA, CATALYTIC; RNA, SMALL INTERFERING; RNA, VIRAL;

HEPATITIS C VIRUS; RNA VIRUSES;

EID: 1542273559     PISSN: 15454576     EISSN: None     Source Type: Journal    
DOI: 10.1089/154545703322860834     Document Type: Review

References (61)

1. AGRAWAL, S., and ZHAO, Q. (1998). Antisense therapeutics. Curr. Opin. Chem. Biol. 2, 519-528.
2. ALI, N., PRUIJN, G.J., KENAN, D.J., KEENE, J.D., and SIDDIQUI, A. (2000). Human La antigen is required for the hepatitis C virus internal ribosome entry site-mediated translation. J. Biol. Chem. 275, 27531-27540.
3. ALI, N., and SIDDIQUI, A. (1995). Interaction of polypyrimidine tract-binding protein with the 5′ noncoding region of the hepatitis C virus RNA genome and its functional requirement in internal initiation of translation. J. Virol. 69, 6367-6375.
4. ALI, N., and SIDDIQUI, A. (1997). The La antigen binds 5′ noncoding region of the hepatitis C virus RNA in the context of the initiator AUG codon and stimulates internal ribosome entry site-mediated translation. Proc. Natl. Acad. Sci. USA 94, 2249-2254.
5. ALT, M., EISENHARDT, S., SERWE, M., RENZ, R., ENGELS, J.W., and CASELMANN, W.H. (1999). Comparative inhibitory potential of differently modified antisense oligodeoxynucleotides on hepatitis C virus translation. Eur. J. Clin. Invest. 29, 868-876.
6. ANWAR, A., ALI, N., TANVEER, R., and SIDDIQUI, A. (2000). Demonstration of functional requirement of polypyrimidine tract-binding protein by SELEX RNA during hepatitis C virus internal ribosome entry site-mediated translation initiation. J. Biol. Chem. 275, 34231-34235.
7. BASTIDE, L., BOEHMER, P.E., VILLANI, G., and LEBLEU, B. (1999). Inhibition of a DNA-helicase by peptide nucleic acids. Nucleic Acids Res. 27, 551-554.
8. BROWN-DRIVER, V., ETO, T., LESNIK, E., ANDERSON, K.P., and HANECAK, R.C. (1999). Inhibition of translation of hepatitis C virus RNA by 2-modified antisense oligonucleotides. Antisense Nucleic Acid Drug Dev. 9, 145-154.
9. BÜSEN, W., and FRANK, P. (1998). Bovine ribonucleases H. In: Ribonuclease H. R.J. Crouch and J.J. Toulmé, eds. (INSERM, Paris), pp. 113-146.
10. CAZENAVE, C., FRANK, P., and BUSEN, W. (1993). Characterization of ribonuclease H activities present in two cell-free protein synthesizing systems, the wheat germ extract and the rabbit reticulocyte lysate. Biochimie 75, 113-122.
11. CHOO, Q.L., KUO, G., WEINER, A.J., OVERBY, L.R., BRADLEY, D.W., and HOUGHTON, M. (1989). Isolation of a cDNA clone derived from a blood-borne non-A, non-B viral hepatitis genome. Science 244, 359-362.
12. ELBASHIR, S.M., HARBORTH, J., LENDECKEL, W., YALCIN, A., WEBER, K., and TUSCHL, T. (2001). Duplexes of 21-nucleotide RNAs mediate RNA interference in cultured mammalian cells. Nature 411, 494-498.
13. FUKUDA, K., VISHINUVARDHAN, D., SEKIYA, S., KAKIUCHI, N., SHIMOTOHNO, K., KUMAR, P.K., and NISHIKAWA, S. (1997). Specific RNA aptamers to NS3 protease domain of hepatitis C virus. Nucleic Acids Symp. Ser. 37, 237-238.
14. FUKUSHI, S., OKADA, M., KAGEYAMA, T., HOSHINO, F.B., NAGAI, K., and KATAYAMA, K. (2001). Interaction of poly(rC)-binding protein 2 with the 5′-terminal stem loop of the hepatitis C-virus genome. Virus Res. 73, 67-79.
15. HAHM, B., KIM, Y.K., KIM, J.H., KIM, T.Y., and JANG, S.K. (1998). Heterogeneous nuclear ribonucleoprotein L interacts with the 3′ border of the internal ribosomal entry site of hepatitis C virus. J. Virol. 72, 8782-8788.
16. HANECAK, R., BROWN-DRIVER, V., FOX, M.C., AZAD, R.F., FURUSAKO, S., NOZAKI, C., FORD, C., SASMOR, H., and ANDERSON, K.P. (1996). Antisense oligonucleotide inhibition of hepatitis C virus gene expression in transformed hepatocytes. J. Virol. 70, 5203-5212.
17. HEINTGES, T., ENCKE, J., ZU PUTLITZ, J., and WANDS, J.R. (2001). Inhibition of hepatitis C virus NS3 function by antisense oligodeoxynucleotides and protease inhibitor. J. Med. Virol. 65, 671-680.
18. HONDA, M., BEARD, M.R., PING, L.H., and LEMON, S.M. (1999). A phylogenetically conserved stem-loop structure at the 5′ border of the internal ribosome entry site of hepatitis C virus is required for cap-independent viral translation. J. Virol. 73, 1165-1174.
19. HONDA, M., BROWN, E.A., and LEMON, S.M. (1996). Stability of a stem-loop involving the initiator AUG controls the efficiency of internal initiation of translation on hepatitis C virus RNA. RNA 2, 955-968.
20. HONDA, M., KANEKO, S., MATSUSHITA, E., KOBAYASHI, K., ABELL, G.A., and LEMON, S.M. (2000). Cell cycle regulation of hepatitis C virus internal ribosomal entry sitedirected translation. Gastroenterology 118, 152-162.
21. HOOFNAGLE, J.H. (1997). Hepatitis C: The clinical spectrum of disease. Hepatology 26, 15S-20S.
22. ISHIDO, S., FUJITA, T., and HOTTA, H. (1998). Complex formation of NS5B with NS3 and NS4A proteins of hepatitis C virus. Biochem. Biophys. Res. Commun. 244, 35-40.
23. ISOYAMA, T., KAMOSHITA, N., YASUI, K., IWAI, A., SHIROKI, K., TOYODA, H., YAMADA, A., TAKASAKI, Y., and NOMOTO, A. (1999). Lower concentration of La protein required for internal ribosome entry on hepatitis C virus RNA than on poliovirus RNA. J. Gen. Virol. 80, 2319-2327.
24. JUBIN, R., VANTUNO, N.E., KIEFT, J.S., MURRAY, M.G., DOUDNA, J.A., LAU, J.Y., and BAROUDY, B.M. (2000). Hepatitis C virus internal ribosome entry site (IRES) stem loop IIId contains a phylogenetically conserved GGG triplet essential for translation and IRES folding. J. Virol. 74, 10430-10437.
25. KAMINSKI, A., HUNT, S.L., PATTON, J.G., and JACKSON, R.J. (1995). Direct evidence that polypyrimidine tract binding protein (PTB) is essential for internal initiation of translation of encephalomyocarditis virus RNA. RNA 1, 924-938.
26. KAPADIA, S.B., BRIDEAU-ANDERSEN, A., and CHISARI, F.V. (2003). Interference of hepatitis C virus RNA replication by short interfering RNAs. Proc. Natl. Acad. Sci. USA 100, 2014-2018.
27. KIEFT, J.S., GRECH, A., ADAMS, P., and DOUDNA, J.A. (2001a). Mechanisms of internal ribosome entry in translation initiation. Cold Spring Harb. Symp. Quant. Biol. 66, 277-283.
28. KIEFT, J.S., ZHOU, K., JUBIN, R., and DOUDNA, J.A. (2001b). Mechanism of ribosome recruitment by hepatitis C IRES RNA. RNA 7, 194-206.
29. KIEFT, J.S., ZHOU, K., JUBIN, R., MURRAY, M.G., LAU, J.Y., and DOUDNA, J.A. (1999). The hepatitis C virus internal ribosome entry site adopts an ion-dependent tertiary fold. J. Mol. Biol. 292, 513-529.
30. KLINCK, R., WESTHOF, E., WALKER, S., AFSHAR, M., COLLIER, A., and ABOULELA, F. (2000). A potential RNA drug target in the hepatitis C virus internal ribosomal entry site. RNA 6, 1423-1431.
31. KOLUPAEVA, V.G., PESTOVA, T.V., and HELLEN, C.U. (2000). An enzymatic footprinting analysis of the interaction of 40S ribosomal subunits with the internal ribosomal entry site of hepatitis C virus. J. Virol. 74, 6242-6250.
32. KOZAK, M. (1989). The scanning model for translation: An update. J. Cell Biol. 108, 229-241.
33. KUMAR, P.K., MACHIDA, K., URVIL, P.T., KAKIUCHI, N., VISHNUVARDHAN, D., SHIMOTOHNO, K., TAIRA, K., and NISHIKAWA, S. (1997), Isolation of RNA aptamers specific to the NS3 protein of hepatitis C virus from a pool of completely random RNA. Virology 237, 270-282.
34. LIEBER, A., HE, C.Y., POLYAK, S.J., GRETCH, D.R., BARR, D., and KAY, M.A. (1996). Elimination of hepatitis C virus RNA in infected human hepatocytes by adenovirusmediated expression of ribozymes. J. Virol. 70, 8782-8791.
35. LIMA, W.F., BROWN-DRIVER, V., FOX, M., HANECAK, R., and BRUICE, T.W. (1997). Combinatorial screening and rational optimization for hybridization to folded hepatitis C virus RNA of oligonucleotides with biological antisense activity. J. Biol. Chem. 272, 626-638.
36. LUKAVSKY, P.J., OTTO, G.A., LANCASTER, A.M., SARNOW, P., and PUGLISI, J.D. (2000). Structures of two RNA domains essential for hepatitis C virus internal ribosome entry site function. Nat. Struct. Biol. 7, 1105-1110.
37. MICHEL, T., MARTINAND-MARI, C., DEBART, F., LEBLEU, B., ROBBINS, I., and VASSEUR, J.J. (2003). Cationic phosphoramidate alpha-oligonucleotides efficiently target single-stranded DNA and RNA and inhibit hepatitis C virus IRES-mediated translation. Nucleic Acids Res. 31, 5282-5290.
38. Molecule of the month: Heptazyme. (2000). Drug News Perspect. 13, 112.
39. NADAL, A., MARTELL, M., LYTLE, J.R., LYONS, A.J., ROBERTSON, H.D., CABOT, B., ESTEBAN, J.I., ESTEBAN, R., GUARDIA, J., and GOMEZ, J. (2002). Specific cleavage of hepatitis C virus RNA genome by human RNase P. J. Biol. Chem. 277, 30606-30613.
40. NADAL, A., ROBERTSON, H.D., GUARDIA, J., and GOMEZ, J. (2003). Characterization of the structure and variability of an internal region of hepatitis C virus RNA for M1 RNA guide sequence ribozyme targeting. J. Gen. Virol. 84, 1545-1548.
41. OPALINSKA, J.B., and GEWIRTZ, A.M. (2002). Nucleic-acid therapeutics: Basic principles and recent applications. Nat. Rev. Drug Discov. 1, 503-514.
42. PESTOVA, T.V., HELLEN, C.U., and SHATSKY, I.N. (1996). Canonical eukaryotic initiation factors determine initiation of translation by internal ribosomal entry. Mol. Cell Biol. 16, 6859-6869.
43. PESTOVA, T.V., SHATSKY, I.N., FLETCHER, S.P., JACKSON, R.J., and HELLEN, C.U. (1998). A prokaryotic-like mode of cytoplasmic eukaryotic ribosome binding to the initiation codon during internal translation initiation of hepatitis C and classical swine fever virus RNAs. Genes Dev. 12, 67-83.
44. RANDALL, G., GRAKOUI, A., and RICE, C.M. (2003). Clearance of replicating hepatitis C virus replicon RNAs in cell culture by small interfering RNAs. Proc. Natl. Acad. Sci. USA 100, 235-240.
45. RIJNBRAND, R.C., and LEMON, S.M. (2000). Internal ribosome entry site-mediated translation in hepatitis C virus replication. Curr Top Microbiol. Immunol. 242, 85-116.
46. ROBERTSON, B., MYERS, G., HOWARD, C., BRETTIN, T., BUKH, J., GASCHEN, B., GOJOBORI, T., MAERTENS, G., MIZOKAMI, M., NAINAN, O., NETESOV, S., NISHIOKA, K., SHIN I, T., SIMMONDS, P., SMITH, D., STUYVER, L., and WEINER, A. (1998). Classification, nomenclature, and database development for hepatitis C virus (HCV) and related viruses: Proposals for standardization. International Committee on Virus Taxonomy. Arch. Virol. 143, 2493-2503.
47. SMITH, D.B., and SIMMONDS, P. (1997). Characteristics of nucleotide substitution in the hepatitis C virus genome: Constraints on sequence change in coding regions at both ends of the genome. J. Mol. Evol. 45, 238-246.
48. SPAHN, C.M., KIEFT, J.S., GRASSUCCI, R.A., PENCZEK, P.A., ZHOU, K., DOUDNA, J.A., and FRANK, J. (2001). Hepatitis C virus IRES RNA-induced changes in the conformation of the 40s ribosomal subunit. Science 291, 1959-1962.
49. SPANGBERG, K., and SCHWARTZ, S. (1999). Poly(C)-binding protein interacts with the hepatitis C virus 5′ untranslated region. J. Gen. Virol. 80, 1371-1376.
50. STEPHENS, A.C., and RIVERS, R.P. (2003). Antisense oligonucleotide therapy in cancer. Curr. Opin. Mol. Ther. 5, 118-122.
51. TACKETT, A.J., WEI, L., CAMERON, C.E., and RANEY, K.D. (2001). Unwinding of nucleic acids by HCV NS3 helicase is sensitive to the structure of the duplex. Nucleic Acids Res. 29, 565-572.
52. TALLET-LOPEZ, B., ALDAZ-CARROLL, L., CHABAS, S., DAUSSE, E., STAEDEL, C., and TOULMÉ, J.J. (2003). Antisense oligonucleotides targeted to the domain IIId of the hepatitis C virus IRES compete with 40S ribosomal subunit binding and prevent in vitro translation. Nucleic Acids Res. 31, 734-742.
53. TANAKA, Y., SHIMOIKE, T., ISHII, K., SUZUKI, R., SUZUKI, T., USHIJIMA, H., MATSUURA, Y., and MIYAMURA, T. (2000). Selective binding of hepatitis C virus core protein to synthetic oligonucleotides corresponding to the 5′ untranslated region of the viral genome. Virology 270, 229-236.
54. URVIL, P.T., KAKIUCHI, N., ZHOU, D.M., SHIMOTOHNO, K., KUMAR, P.K., and NISHIKAWA, S. (1997). Selection of RNA aptamers that bind specifically to the NS3 protease of hepatitis C virus. Eur. J. Biochem. 248, 130-138.
55. VIDALIN, O., MAJOR, M.E., RAYNER, B., IMBACH, J.L., TREPO, C., and INCHAUSPE, G. (1996). In vitro inhibition of hepatitis C virus gene expression by chemically modified antisense oligodeoxynucleotides. Antimicrob. Agents Chemother. 40, 2337-2344.
56. WAKITA, T., and WANDS, J.R. (1994). Specific inhibition of hepatitis C virus expression by antisense oligodeoxynucleotides. In vitro model for selection of target sequence. J. Biol. Chem. 269, 14205-14210.
57. WANG, C., LE, S.Y., ALI, N., and SIDDIQUI, A. (1995). An RNA pseudoknot is an essential structural element of the internal ribosome entry site located within the hepatitis C virus 5′ noncoding region. RNA 1, 526-537.
58. WANG, C., SARNOW, P., and SIDDIQUI, A.,(1994). A conserved helical element is essential for internal initiation of translation of hepatitis C virus RNA. J. Virol. 68, 7301-7307.
59. WELCH, P.J., TRITZ, R., YEI, S., LEAVITT, M., YU, M., and BARBER, J. (1996). A potential therapeutic application of hairpin ribozymes: In vitro and in vivo studies of gene therapy for hepatitis C virus infection. Gene Ther. 3, 994-1001.
60. WITHERELL, G.W. (2001). ISIS-14803 (Isis Pharmaceuticals). Curr. Opin. Invest. Drugs 2, 1523-1529.
61. ZHANG, H., HANECAK, R., BROWN-DRIVER, V., AZAD, R., CONKLIN, B., FOX, M.C., and ANDERSON, K.P. (1999). Antisense oligonucleotide inhibition of hepatitis C virus (HCV) gene expression in livers of mice infected with an HCV-vaccinia virus recombinant. Antimicrob. Agents Chemother. 43, 347-353.